Clinical Trials Browser

Recruiting × OTHER_GOV × Drug Therapy × Clear all

NCT07472153 2026-03-16

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Phase 2/3 Recruiting

Uterine Cervical Neoplasms

NCT06709859 2025-07-17

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06617936 2025-07-15

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Phase 2 Recruiting

Unresectable Non-small Cell Lung Cancer

NCT06551857 2025-04-16

CaSPiN

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

NCT06670911 2025-02-24

ACCESS-I

Phase 2 Recruiting

Recurrence

NCT06449937 2024-06-10

Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

Phase NA Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT05599698 2024-05-14

Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer

Phase NA Recruiting

Neoplasms

NCT06406608 2024-05-09

Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung